Lorazepam: Package Insert and Label Information (Page 3 of 3)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 2 mg

NDC 68788-7533
Lorazepam Tablets USP CIV
2 mg
Rx only
AUROBINDO

Repackaged by Preferred Pharmaceuticals, Inc.

Lorazepam Tablets USP 2mg (CIV)
(click image for full-size original)

LORAZEPAM lorazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68788-7533(NDC:13107-085)
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LORAZEPAM (LORAZEPAM) LORAZEPAM 2 mg
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS LACTOSE
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
POLACRILIN POTASSIUM
Product Characteristics
Color WHITE (White to off white) Score 2 pieces
Shape ROUND (Flat-faced beveled edge) Size 7mm
Flavor Imprint Code U34
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68788-7533-3 30 TABLET in 1 BOTTLE None
2 NDC:68788-7533-6 60 TABLET in 1 BOTTLE None
3 NDC:68788-7533-9 90 TABLET in 1 BOTTLE None
4 NDC:68788-7533-1 100 TABLET in 1 BOTTLE None
5 NDC:68788-7533-8 120 TABLET in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA203572 03/24/2017
Labeler — Preferred Pharmaceuticals, Inc. (791119022)
Registrant — Preferred Pharmaceuticals, Inc. (791119022)
Establishment
Name Address ID/FEI Operations
Preferred Pharmaceuticals, Inc. 791119022 REPACK (68788-7533)

Revised: 08/2022 Preferred Pharmaceuticals, Inc.

Page 3 of 3 1 2 3

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2022. All Rights Reserved.